Skip to main content
74°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Geron Corporation
< Previous
1
2
3
4
5
Next >
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
June 15, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports First Quarter 2022 Financial Results
May 09, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Announce First Quarter 2022 Financial Results on May 9, 2022
May 02, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
April 01, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
March 30, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
March 29, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
January 21, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the H.C. Wainwright BioConnect Conference
January 04, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Presentations at American Society of Hematology Annual Meeting
December 14, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Appointment of Chief Business Officer
December 02, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
November 12, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Presents Investor Event Highlights
November 09, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
November 04, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
October 25, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 21, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
October 18, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Host a Virtual Investor Event in November
October 15, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
October 11, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 16, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces September Investor Conference Presentation Webcasts
September 01, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 19, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
August 16, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
